The results showed that upregulation of SMC1A, 2, 3, 4, and 5 was associated with the poor OS and decreased survival when PAAD patients were enriched with CD8+ T-cells (Figure 7A) and B-cells (Figure 7B). The gene discussed is CD8A; the disease is pancreatic adenocarcinoma.